Deferred Tax Assets, Valuation Allowance in USD of NOVAVAX INC from Q4 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NOVAVAX INC quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2011 to Q4 2024.
  • NOVAVAX INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $1.14B, a 0.59% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

NOVAVAX INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.14B +$6.62M +0.59% 31 Dec 2024 10-K 27 Feb 2025
Q4 2023 $1.13B +$109M +10.7% 31 Dec 2023 10-K 27 Feb 2025
Q4 2022 $1.02B +$4.79M +0.47% 31 Dec 2022 10-K 28 Feb 2024
Q4 2021 $1.02B +$511M +101% 31 Dec 2021 10-K 28 Feb 2023
Q4 2020 $505M +$139M +38% 31 Dec 2020 10-K 01 Mar 2022
Q4 2019 $366M +$28.3M +8.37% 31 Dec 2019 10-K 01 Mar 2021
Q4 2018 $338M +$37.7M +12.6% 31 Dec 2018 10-K 11 Mar 2020
Q4 2017 $300M -$54.7M -15.4% 31 Dec 2017 10-K 18 Mar 2019
Q4 2016 $355M +$118M +49.7% 31 Dec 2016 10-K 14 Mar 2018
Q4 2015 $237M +$63.9M +37% 31 Dec 2015 10-K 27 Feb 2017
Q4 2014 $173M +$30.4M +21.3% 31 Dec 2014 10-K 29 Feb 2016
Q4 2013 $143M +$7.12M +5.26% 31 Dec 2013 10-K 27 Feb 2015
Q4 2012 $135M +$9.4M +7.46% 31 Dec 2012 10-K 12 Mar 2014
Q4 2011 $126M 31 Dec 2011 10-K 12 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.